Ginkgo biloba extract (银杏叶提取物) is a standardized botanical preparation derived from the leaves of Ginkgo biloba, one of the oldest living tree species on Earth — often called a "living fossil" because it has remained virtually unchanged for over 200 million years. The extract is one of the most extensively studied herbal medicines in the world, with over 500 peer-reviewed clinical trials and a global market exceeding $2.5 billion annually.
Ginkgo biloba extract is the most widely prescribed herbal medicine in Germany and France, and it ranks among the top 10 best-selling herbal supplements in the United States. Its standardized formulation, known as EGb 761, has been the subject of decades of clinical research demonstrating efficacy for cognitive support, circulatory health, and antioxidant protection.
The global ginkgo biloba extract market continues to grow, driven by aging populations in developed countries, increasing prevalence of cognitive decline, and expanding applications in cosmeceuticals and functional foods.
supplies premium Ginkgo biloba leaf extract standardized to 24% flavone glycosides and 6% terpene lactones — the internationally recognized pharmacopoeia standard — produced through advanced extraction and purification processes with rigorous quality control.
Ginkgo biloba extract contains two major groups of bioactive compounds:
Flavone Glycosides (24%):
Quercetin, kaempferol, and isorhamnetin derivatives
Potent antioxidants that protect neurons and vascular endothelium from oxidative damage
Improve vascular permeability and reduce capillary fragility
Terpene Lactones (6%):
Ginkgolides A, B, C: Unique to Ginkgo biloba; potent platelet-activating factor (PAF) antagonists
Ginkgolide B: The most biologically active PAF antagonist known
Bilobalide: Neuroprotective sesquiterpene that protects against excitotoxicity
Removed components: Ginkgo biloba extract production removes ginkgolic acids (which are allergenic and potentially cytotoxic) to <5 ppm, ensuring safety for human consumption.
Mechanism Effect Clinical Relevance PAF antagonism Reduced platelet aggregation, improved microcirculation Peripheral arterial disease, tinnitus Vasodilation Enhanced blood flow via nitric oxide pathways Cerebral insufficiency, cognitive support Antioxidant protection Free radical scavenging, lipid peroxidation inhibition Neuroprotection, anti-aging Neurotransmitter modulation Increased cholinergic and dopaminergic activity Memory, attention, mood Neurotrophic factor support Enhanced BDNF and NGF expression Neurogenesis, synaptic plasticity Anti-inflammatory NF-κB pathway modulation Chronic inflammation, neurodegeneration
Specification Details Active Ingredients Flavone glycosides (24%) + Terpene lactones (6%) Ginkgolic Acids <5 ppm (EU pharmacopoeia requirement) Botanical Source Ginkgo biloba L. (leaves) Extraction Method Ethanol/water extraction, multi-stage purification Appearance Light yellow to brownish-yellow fine powder Ratio 50:1 (concentrated extract) Heavy Metals Pb <2ppm, As <1ppm, Cd <0.5ppm, Hg <0.1ppm Pesticide Residues Compliant with EU/US pharmacopoeia limits
Ginkgo biloba extract is the most researched herbal ingredient for cognitive health:
Age-related cognitive decline: A systematic review of 36 RCTs (2020) found standardized Ginkgo extract (EGb 761) significantly improved cognitive function, activities of daily living, and neuropsychiatric symptoms in patients with dementia
Healthy adults: Studies show improvements in processing speed, working memory, and attention after acute and chronic supplementation
Clinical dose: 120–240 mg/day of standardized extract (24/6) for cognitive support
Onset of effects: Acute improvements within 1–2 hours; cumulative benefits typically observed after 4–6 weeks
Intermittent claudication: Multiple RCTs demonstrate Ginkgo extract significantly increases pain-free walking distance in patients with peripheral arterial disease
Raynaud's phenomenon: Improves peripheral blood flow and reduces symptom frequency
Diabetic microangiopathy: Supports microcirculation in diabetic patients, potentially reducing complications
Glaucoma: Ginkgo extract improves blood flow to the optic nerve and may slow visual field loss in normal-tension glaucoma
Diabetic retinopathy: Antioxidant and vasoprotective effects may slow disease progression
Macular degeneration: Improves retinal blood flow and protects retinal cells from oxidative damage
Ginkgo extract is widely used in Europe for tinnitus management, particularly when associated with vascular insufficiency
A meta-analysis found significant improvement in tinnitus symptoms with standardized Ginkgo extract (240 mg/day) compared to placebo
Also shows benefit in sudden sensorineural hearing loss when combined with conventional treatment
Emerging evidence suggests Ginkgo biloba extract may reduce symptoms of generalized anxiety disorder
A double-blind RCT (2017) found 240 mg/day of Ginkgo extract significantly reduced anxiety symptoms after 4 weeks
Proposed mechanisms include modulation of the HPA axis and enhancement of GABAergic signaling
The EGb 761 formulation (developed by Dr. Willmar Schwabe Pharmaceuticals) established the gold standard for Ginkgo biloba extract:
24% flavone glycosides: Consistent antioxidant and vasoprotective activity
6% terpene lactones: Reliable PAF antagonism and neuroprotection
<5 ppm ginkgolic acids: Safety threshold for allergic reactions
produces Ginkgo biloba extract to this exact standard, ensuring consistent therapeutic activity batch after batch.
Red Flag Risk Unstandardized leaf powder Variable potency; unpredictable effects Ginkgolic acids >5 ppm Allergic reactions; cytotoxicity No HPLC certificate of analysis Cannot verify active compound content Non-pharmacopoeia grade May fail regulatory compliance in EU/US
, established in 2004, is a professional natural plant extract manufacturer with over 20 years of experience in botanical extraction and quality control.
Standardized to 24% flavone glycosides + 6% terpene lactones (EGb 761 equivalent)
Ginkgolic acids <5 ppm (EU pharmacopoeia compliant)
ISO22000, BRCGS, Ecocert Organic, SGS-GMP certified manufacturing
Multi-stage purification ensuring consistent potency and safety
Independent laboratory with HPLC, GC, UV analysis capabilities
100,000-grade clean production area for food-grade products
Export experience across Europe, the United States, South Korea, and Russia
The standard clinical dose is 120–240 mg/day of standardized extract (24% flavone glycosides, 6% terpene lactones), typically divided into 2–3 doses. For cognitive support, 120 mg twice daily is the most common regimen.
Acute effects on blood flow and attention may be felt within 1–2 hours. For cognitive benefits, 4–6 weeks of consistent supplementation is typically required. For peripheral circulation improvement, 8–12 weeks may be needed.
Yes. Ginkgo extract has mild antiplatelet effects and may enhance the effects of blood thinners (warfarin, aspirin, clopidogrel). Consult a healthcare provider before combining.
Ginkgo leaf powder is simply dried, ground leaves with variable active compound content. Standardized Ginkgo extract (24/6) is a concentrated, purified preparation with consistent, verified levels of flavone glycosides and terpene lactones — the form used in all clinical trials.
Please
2026-10-27
2026-10-27
2026-10-27
2026-10-27
2026-10-27
2026-10-27
2026-10-27
2026-10-27
2026-10-27
2026-10-27